EIM
UPI

Essex Investment Management’s UROPLASTY INC-NEW UPI Stock Holding History

Essex Investment Management’s Portfolio UPI Stock Details UPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-154,061
Closed -$559K – 402
2014
Q1 		$559K Buy
+154,061
New +$602K 0.08% 237

Other funds holding UPI

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCP
Rothschild Capital Partners New York $408M AUM 25.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Amici Capital New York $257M AUM 4.88% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Essex Investment Management's UPI Position: Q2 2014 in Review

Essex Investment Management sold out of UROPLASTY INC-NEW (UPI) in Q2 2014, closing a stake of 154,061 shares — an estimated $559K sold.

Essex Investment Management first reported a position in UPI in Q1 2014 and held it in 1 quarter. The position peaked at $559K in Q1 2014. 37 funds tracked by Wall St. Rank hold UPI as of Q2 2014.

  • Essex Investment Management reported no remaining UROPLASTY INC-NEW position as of Q2 2014 after selling out during the quarter.
  • Essex Investment Management sold 154,061 UROPLASTY INC-NEW shares in Q2 2014, an estimated $559K.
  • Essex Investment Management first reported a position in UROPLASTY INC-NEW in Q1 2014 and held it in 1 quarter.
  • Essex Investment Management's UROPLASTY INC-NEW position peaked at $559K in Q1 2014.
  • 37 funds tracked by Wall St. Rank held UROPLASTY INC-NEW as of Q2 2014.

Based on Essex Investment Management's 13F filing for Q2 2014, filed 23 Jul 2014.